The Envelope Proteins from SARS-CoV-2 and SARS-CoV Potently Reduce the Infectivity of Human Immunodeficiency Virus type 1 (HIV-1)
Wyatt Henke(University of Kansas Medical Center), Edward B. Stephens(University of Kansas Medical Center)
Cited by 0
Related Papers
The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)
|Retrovirology|2022|4
The Envelope Protein of SARS-CoV-2 Inhibits Viral Protein Synthesis and Infectivity of Human Immunodeficiency Virus type 1 (HIV-1)
|bioRxiv (Cold Spring Harbor Laboratory)|2022|2